Intensive chemotherapy with autologous b
โ
R. L. Souhami; H. T. Hajichristou; D. W. Miles; H. M. Earl; P. G. Harper; C. M.
๐
Article
๐
1989
๐
Springer
๐
English
โ 526 KB
Since 1980, 75 patients with small-cell lung cancer (SCLC) have been entered into four consecutive studies of high-dose chemotherapy using autologous bone marrow transplantation (ABMT) to assist haematological recovery. In the first study, 25 patients were treated with cyclophosphamide (160-200 mg/k